Insights On Trial Design

1. Navigating The CrowdStrike Outage With Hybrid Meeting Solutions 8/7/2024

   When the July 2024 CrowdStrike outage caused widespread disruptions to attendees' travel plans, Scout jumped into action with hybrid meeting solutions to rescue a rare disease Investigators' Meeting.

2. Redefining Accessibility For Pediatric Patients 9/24/2025

   Explore how meeting patients where they are can redefine what successful pediatric trial delivery looks like.

3. Redefining Evidence Generation In Modern Clinical Trials 8/2/2024

   As trials continue to digitize, learn how connected sensors, COAs, PROs, and other forms of data will come together to form the evidence of tomorrow.

4. Navigating The Confluence Of AI And Community-Based Trials 10/11/2024

   Artificial intelligence (AI) is transforming clinical trials, enhancing efficiency, participation, and diversity, particularly within hybrid trial models.

5. Market Approval For A Novel Non-Hodgkin Lymphoma (NHL) Therapy 4/11/2025

   Explore a collaboration that underscores the importance of strategic planning and regulatory engagement in the approval process.

6. Clinical Trial Access In The U.S.: Where Are Today's Trials Missing? 7/9/2024

   Access to clinical trials in the U.S. is uneven, leaving many regions underserved. Let's examine site distribution, the impact of healthcare deserts, and ways to improve trial accessibility for all Americans.

7. Rethinking Effectiveness: Balancing Tradeoffs In An Era Of Disruption 11/12/2025

   In an era defined by rapid disruption and technological advancement, clinical operations leaders are under increasing pressure to enhance effectiveness while managing complex strategic trade-offs.

8. How AI Is Reshaping Trial Design, Execution, And Disclosure 9/25/2025

   AI has quietly embedded itself into the operational heart of clinical development, where it is accelerating decisions, reducing manual burden, and improving outcomes.

9. How Smarter Financial Strategies Improve Trial Performance 3/10/2025

   CROs play a critical role in ensuring the financial and operational success of clinical trials, yet outdated budgets and inefficient payment processes continue to create challenges for sites.

10. Rare Disease R&D: Continued Growth Amid Challenges 3/21/2025

    The market for rare disease treatments continues to grow but it is not without its challenges, including small patient populations and a lack of existing research.